Sign in

GlycoTime Digests

@glycotime.bsky.social
276 followers 450 following 1 posts

Water cooler for glycoscientists - human curation

PostsRepliesMedia
Reposted by GlycoTime Digests
Carolyn Bertozzi @carolynbertozzi.bskyverified.social · 09/06/2025
Please join the chorus of voices, including my own, in support of the talented, hardworking and dedicated scientists and staff at NIH. They serve their country by deploying their training and skills to improve the health and quality of life of all Americans 🙏 🇺🇸
313151
Reposted by GlycoTime Digests
Carolyn Bertozzi @carolynbertozzi.bskyverified.social · 09/06/2025
Article by @cenmag.bsky.social on the #BethesdaDeclaration by NIH scientists and staff released earlier this morning: cen.acs.org/policy/resea...
cen.acs.org
NIH staff break ranks in open letter to Director Jay Bhattacharya
Bethesda Declaration urges reversal of recent policies, including funding cuts
03512
Reposted by GlycoTime Digests
Elisa Fadda @elisafadda.bsky.social · 10/06/2025
Wow #glycotime from @msollogoub.bsky.social @vivesgui.bsky.social and colleagues 👏🏻👏🏻👏🏻🎉🤩 Super congrats! ⤵️ #chemsky
041
Reposted by GlycoTime Digests
Elisa Fadda @elisafadda.bsky.social · 11/06/2025
Too cool to be true? 😎 Nope! GlycoShape ReGlyco runs on PyMol through the GlycoMe interface 🥰😍 check out this fab #glycotime tool from Hiren @glyco.me and Ojas @ojas-singh.bsky.social ⤵️🥳🥳🥳🎉🎉
1198
Reposted by GlycoTime Digests
Hiren Joshi @glyco.me · 10/06/2025
Well, it turns out that you can actually make PyMOL do quite a lot of stuff. Here's the full workflow, integrating the amazing ReGlyco into PyMOL to re-glycosylate the LDLA linker. There's some serious magic needed to get it running as fast as it is within PyMOL. @elisafadda.bsky.social
2276
Reposted by GlycoTime Digests
MCGalan Lab @mcgalanlab.bsky.social · 11/06/2025
Congratulations to the team @BristolChem and collaborators in China #Voglmeir's team & Spain @MattiaGhirarde2 for the fantastic team effort on developing a new Imidazolium Tag (DAPMI-ITag) for Precise Sialic Acid Detection in Human Serum and CMAH-Null Mouse Tissues pubs.acs.org/doi/10.1021/...
pubs.acs.org
Improved ESI-MS Sensitivity via an Imidazolium Tag (DAPMI-ITag) for Precise Sialic Acid Detection in Human Serum and CMAH-Null Mouse Tissues
Sialic acids (Sias), consisting primarily of N-acetylneuraminic acid (Neu5Ac) and N-glycolylneuraminic acid (Neu5Gc), play crucial roles in many biological processes. The detection and quantification of Sias are essential for understanding their roles in health and disease progression. Although numerous techniques have been developed to enhance the specificity and sensitivity of Sias analysis, traditional methods such as derivatization with fluorescent tags coupled with HPLC-MS analysis often suffer from low limits of detection, limiting the quantification of Sias in trace samples. Here, we introduce DAPMI, a novel imidazolium-based ITag for sensitive Sia detection. We demonstrate its utility in the detection and quantification of Sia composition in human serum, and in different tissues from CMAH (cytidine monophosphate-N-acetylneuraminic acid hydroxylase) knockout mice, using ESI-MS analysis and with a limit of detection (LOD) down to the low fmol range. The results showed that both Neu5Ac and Neu5Gc were present in varying proportions in wild-type mice and CMAH heterogeneous mice. Trace amounts of Neu5Gc were also detected in the tissues of CMAH null homogeneous mice (CMAH–/−) and in human blood serum using ESI-ToF-MS, suggesting its presence may be linked to dietary intake of Neu5Gc-containing foods, as Neu5Gc cannot be synthesized endogenously in CMAH–/– mice, and in humans. The DAPMI-ITag and the labeling technology developed in this study significantly improve the sensitivity of Sias detection compared to conventional tags such as o-phenylenediamine (OPD), and provide a new chemical tool for the exploration of Sias’ biological roles and their use as biomarkers in different human conditions.
122
Reposted by GlycoTime Digests
Marcin Czerwinski @czerwinsmarcin.bsky.social · 03/06/2025
Marcin Czerwinski Interesting review about glycoRNAs as immune regulators. tinyurl.com/mvutz9ye #glycotime
064
Reposted by GlycoTime Digests
GlycoNet @glyconet.bsky.social · 13/02/2025
We’re thrilled to feature an incredible lineup of plenary speakers at #Glyco27! These experts will share cutting-edge insights and the latest advancements in glycomics across areas of health, including immunology, neuroscience and more! Register today: glyco27.org/en/begin @glycotime.bsky.social
063
Reposted by GlycoTime Digests
GlycoNet @glyconet.bsky.social · 10/02/2025
@glycotime.bsky.social @ozglyco.bsky.social @glycosmos.bsky.social @glygen.bsky.social @giaglyco.bsky.social #glycoscience #glycomics #glycans #CallForAbstracts #glycobiology
013
Reposted by GlycoTime Digests
Luciano A. Masullo @lumasullo.bsky.social · 10/02/2025
ÅNGSTRÖM-RESOLUTION IMAGING OF CELL-SURFACE GLYCANS 🧬🎨🍬 The glycocalyx, our cells' sugar coat, holds secrets in immunology, cancer, viral infections, and more. Visualizing its molecular architecture was impossible… until now. #glycotime #microscopy www.biorxiv.org/content/10.1...
15313101
Reposted by GlycoTime Digests
Carolyn Bertozzi @carolynbertozzi.bskyverified.social · 10/02/2025
This is an amazing achievement - angstrom scale imagine of glycan molecules, what a great time for #glycotime. Congrats Leonhard Möckl! www.biorxiv.org/content/10.1...
biorxiv.org
Angstrom-resolution imaging of cell-surface glycans
Glycobiology is rooted in the study of monosaccharides, Angstrom-sized molecules that are the building blocks of intricate glycosylation patterns. Glycosylated biomolecules form the glycocalyx, a dens...
19419
Reposted by GlycoTime Digests
Chris Ashwood @cashwood.proteaglyco.com · 10/02/2025
Woah. Should be a nice way to validate in-solution computational models of glycans.
041
Reposted by GlycoTime Digests
Brett Garabedian, PhD @brettgarabedian.bsky.social · 27/01/2025
View from the office today 🌈 Someone needs to check the hole on the 8th green..
001
GlycoTime Digests @glycotime.bsky.social · 28/01/2025
Don’t forget to submit your abstracts by Feb 10, 2025 @glyconet.bsky.social
011
Reposted by GlycoTime Digests
GlycoNet @glyconet.bsky.social · 23/01/2025
📰Our January 2025 newsletter is out now! Don’t miss news about #Glyco27, IGO Award recipients, research & training opportunities! Read here: mailchi.mp/5547444d411c... @glycotime.bsky.social #glycomics
mailchi.mp
GlycoNet News - January 2025
022
Reposted by GlycoTime Digests
GlycoNet @glyconet.bsky.social · 27/01/2025
🚨Call for abstracts for #Glyco27 Submit your abstract by Feb 10, 2025 Themes: Glycomics, Glycobiology of Disease, Tools to Drive Glycobiology, Glycans in Immunology, and Emerging Concepts in Glycans More info: glyco27.org/en/callforab... @glycotime.bsky.social #glycomics #Abstracts
022
Reposted by GlycoTime Digests
Usha Lee McFarling @usha.bsky.social · 26/01/2025
Please repost! We’re trying hard to sort out rumors from truth + would like to hear from anyone affected by the new federal orders + NIH pause. Patients, scientists, health equity researchers: please contact us below. We won’t share anything without your permission. www.statnews.com/2025/01/25/t...
statnews.com
Are you affected by the Trump administration’s pause on health communications, science meetings, and reviews?
Have you been affected by the Trump administration’s pause on communications, science meetings, and reviews? @statnews would like to hear from you.
20605608
Reposted by GlycoTime Digests
Peng Wu @pengwu.bsky.social · 19/12/2024
Expanding T cells in the presence of mannose can generate T cells with progenitor like properties www.cell.com/cancer-cell/...
cell.com
Mannose metabolism reshapes T cell differentiation to enhance anti-tumor immunity
Qiu et al. identify that reduced mannose metabolism is a key characteristic of T cell dysfunction. Enhancing mannose metabolism in T cells through D-mannose supplementation boosts anti-tumor activity, limits exhaustion differentiation, and maintains T cell stemness. Mechanistically, D-mannose promotes the OGT-mediated O-GlcNAcylation and stabilization of β-catenin, enhancing T cell stemness.
093
Reposted by GlycoTime Digests
Carolyn Bertozzi @carolynbertozzi.bskyverified.social · 19/12/2024
New twist on leveraging modified antibody glycans for site specific bioorthogonal ADC conjugation, featuring #proudofalumni Kevin Yarema and coworkers www.jbc.org/article/S002...
jbc.org
Production of site-specific antibody conjugates using metabolic glycoengineering and novel Fc glycovariants
Molecular conjugation to antibodies has emerged as a growing strategy to combine the mechanistic activities of the attached molecule with the specificity of antibodies. A variety of technologies have been applied for molecular conjugation; however, these approaches face several limitations, including disruption of antibody structure, destabilization of the antibody, and/or heterogeneous conjugation patterns. Collectively, these challenges lead to reduced yield, purity, and function of conjugated antibodies.
0345
Reposted by GlycoTime Digests
Joost Snijder @joostsnijder.bsky.social · 19/12/2024
Interesting design of new ebola/marburg virus inhibitors pubs.acs.org/doi/10.1021/...
pubs.acs.org
Guardians at the Gate: Optimization of Small Molecule Entry Inhibitors of Ebola and Marburg Viruses
Ebola and Marburg (EBOV and MARV) filoviral infections lead to fatal hemorrhagic fevers and have caused over 30 outbreaks in the last 50 years. Currently, there are no FDA-approved small molecule therapeutics for effectively treating filoviral diseases. To address this unmet medical need, we have conducted a systematic structural optimization of an early lead compound, N-(4-(4-methylpiperidin-1-yl)-3-(trifluoromethyl)phenyl)-4-(morpholinomethyl)benzamide (1), borne from our previously reported hit-to-lead effort. This secondary round of structure–activity relationship (SAR) involved the design and synthesis of several deconstructed and reconstructed analogs of compound 1, which were then tested against pseudotyped EBOV and MARV. The antiviral activities of the most promising leads were further validated in infectious assays. The optimized analogs exhibited desirable antiviral activity against different ebolaviruses and reduced off-target activity. Additionally, they also possessed druglike properties, that make them ideal candidates for in vivo efficacy studies as part of our ongoing drug discovery campaign against EBOV and MARV.
074
Reposted by GlycoTime Digests
Fabrizio Chiodo @fabriziochiodo.bsky.social · 19/12/2024
"Collectively, these results demonstrate the ability of the innate and adaptive immune systems to recognize chlorovirus glycoproteins, a process dependent on their specific N-glycan structures..." Our #glycotime study just published @commsbio.bsky.social www.nature.com/articles/s42...
nature.com
Carbohydrate-mediated interactions between chloroviruses and the immune system - Communications Biology
This study explores how viral N-linked glycans play a role in the interaction between chloroviruses glycoproteins and key receptors of the innate immune system.
096
Reposted by GlycoTime Digests
Carolyn Bertozzi @carolynbertozzi.bskyverified.social · 19/12/2024
Exciting news from Palleon Pharma. Engineered sialidases remove glyco-immune checkpoint ligands from B cells, thereby potentiating antibody-mediated B cell depletion for treatment of autoimmune disease. Clinical studies gearing up in partnership with Henlius Biotech #glycotime
businesswire.com
Palleon Pharmaceuticals and Henlius Collaborate to Advance Glycan Editing as a Treatment for Autoimmune Diseases
Palleon Pharmaceuticals, a company pioneering glyco-immunology drug development to treat autoimmune diseases and cancer, today announced a collaborati
2639
Reposted by GlycoTime Digests
Jessica Stark @jcstark.bsky.social · 20/12/2024
Happy holidays from our team to yours ☃️ Looking forward to lots more #glycotime in 2025! @mitdeptofbe.bsky.social
Door to the Stark Lab at MIT decorated for the holidays
062
Reposted by GlycoTime Digests
Chris Ashwood @cashwood.proteaglyco.com · 21/12/2024
Reading this more, this has the potential to be one of the most promising tools for glycoscience. We all know PROTACs (bifunctional molecules that bind to a protein of interest and an E3 ubiquitin ligase), imagine the same thing but for glycans (GLYTAC). Just need to fine-tune the selectivity.
0101
Reposted by GlycoTime Digests
Rachel Hevey @rachelhevey.bsky.social · 21/11/2024
Love #GlycoTime? 💕 Looking forward to chair this afternoon's exciting EGC session featuring: 🦠 Dr. Giorgia Greter @ Swiss biotech start-up Baxiva 🏥 Prof. Lara Mahal @ University of Alberta Registration is still open! Link: unibas.zoom.us/webinar/regi...
Advertisement for the European Glycoscience Webinar on November 21st at 16h CET. The slide features profile photos on the left-hand side of the two speakers, Dr. Giorgia Greter and Prof. Lara Mahal, as well as their webinar titles and institute logos on the right-hand side.
097
Reposted by GlycoTime Digests
Chris Ashwood @cashwood.proteaglyco.com · 21/11/2024
Our best example so far is GlyCombo, our free, open-source software which streamlines the first daunting step of LC-MS data analysis, getting a candidate list of detected glycans. It's fast and complete, improving throughput and enabling discoveries. pubs.acs.org/doi/10.1021/...
pubs.acs.org
GlyCombo Enables Rapid, Complete Glycan Composition Identification across Diverse Glycomic Sample Types
Glycans are sugar-based polymers found to modify biomolecules, including lipids and proteins, as well as occur unconjugated as free polysaccharides. Due to their ubiquitous cellular presentation, glyc...
141
Reposted by GlycoTime Digests
Shira Weingarten-Gabbay @shiraweingarten.bsky.social · 20/11/2024
I'm delighted to share that I will be joining the Department of Microbiology at Harvard Medical School in January 2025. The Laboratory of Systems Virology will study the dark proteome of viral genomes to understand how viruses work their magic🪄 Thrilled to be back in beautiful Boston 🌟
418711
Reposted by GlycoTime Digests
Rémi Hatinguais @remicillin.bsky.social · 19/11/2024
This one is for the #glycotime community: has anyone tried to cleave Lewis X/CD15 from the surface a live mammalian cells using a recombinant fucosidase? I found single paper from 2007 but curious if anyone else has a recent protocol to share 😬
133
Reposted by GlycoTime Digests
Anne Imberty @anneimb.bsky.social · 17/11/2024
Still time to register to awsome Glycobiology Gordon Research Conference 2025. We have a fantastic line of speakers and this will be top #glycotime in Tuscany !! Register at www.grc.org/glycobiology...
03825
Reposted by GlycoTime Digests
Carolyn Bertozzi @carolynbertozzi.bskyverified.social · 19/11/2024
New #glycotime book just came out: www.cambridgescholars.com/product/978-...
cambridgescholars.com
Glycoscience: The Intriguing Area to Understand Human Biology, Health and Disease - Cambridge Scholars Publishing
Glycoscience: The Intriguing Area to Understand Human Biology, Health and Disease - Cambridge Scholars Publishing
1509
Reposted by GlycoTime Digests
Steven Cheng @scheng23.bsky.social · 18/11/2024
Excited to share "Opportunities for Therapeutic Modulation of O-GlcNAc" @acspublications.bsky.social Chemical Reviews with Alison Mody in the Woo lab, our contribution to an upcoming special issue "Drugging the Undruggable". (1/6) pubs.acs.org/doi/10.1021/... #glycotime
pubs.acs.org
Opportunities for Therapeutic Modulation of O-GlcNAc
O-Linked β-N-acetylglucosamine (O-GlcNAc) is an essential, dynamic monosaccharide post-translational modification (PTM) found on serine and threonine residues of thousands of nucleocytoplasmic protein...
1258
Reposted by GlycoTime Digests
Gabriele Corso @gcorso.bsky.social · 17/11/2024
Thrilled to announce Boltz-1, the first open-source and commercially available model to achieve AlphaFold3-level accuracy on biomolecular structure prediction! An exciting collaboration with Jeremy, Saro, and an amazing team at MIT and Genesis Therapeutics. A thread!
18610204
Reposted by GlycoTime Digests
chasingmicrobes @chasingmicrobes.bsky.social · 11/09/2023
If you're a computational chemist/biologist, or simply interested in learning more about #ML/#AI in natural product drug discovery, this is a great place to get an overview of where the field stands. rdcu.be/dlQQw
12511
Reposted by GlycoTime Digests
Amulya Sreekumar @amulyasreekumar.bsky.social · 17/11/2024
Thank you to the organizers of #SFG2024 for hosting a wonderful meeting @sfglycobiology.bsky.social As a 1st time attendee, it was a privilege to present my work on B3galt6-heparan sulfate biosynthesis as a functional regulator of dormant breast cancer cell survival. www.cell.com/cancer-cell/...
cell.com
B3GALT6 promotes dormant breast cancer cell survival and recurrence by enabling heparan sulfate-mediated FGF signaling
Sreekumar et al. identify a previously uncharacterized function for the galactosyltransferase B3galt6 in cancer, specifically enabling dormant residual tumor cell survival following therapy or in a re...
3145
Reposted by GlycoTime Digests
Thorn-Seshold Lab @thornsesholdlab.bsky.social · 17/11/2024
📯📯 Chemical Biology starter pack 📯📯 140 PIs & groups posting primary research in chemical biology. Please reskeet (?) & reply to this post if you want to be added! go.bsky.app/KLrTWoj Let's make ChemBioSky even greater again! #realtimechem #FluorescenceFriday #chemsky #chemtwitter #AgentOrange
48138115
Reposted by GlycoTime Digests
Martin Steinegger 🇺🇦 @martinsteinegger.bsky.social · 17/11/2024
This is the first fully open source release of a AF3 like model. Awesome! Congratulations to the team.
18924
Reposted by GlycoTime Digests
Hiren Joshi @glyco.me · 17/11/2024
For those of you that prefer feeds over following, I've figured out how to convert starter packs into lists, so you can get your glyco fix as a feed. If you're on the starter pack, you're on the list, and anyone new on the starter pack will get added to the feed!
375
Reposted by GlycoTime Digests
Stu Cantrill @stuartcantrill.com · 17/11/2024
“There’s nothing like the nearness of death,” Ward writes, “to make you want to live your very best life… Faced with my mortality, I chose to live fabulously.” Lovely interview with Mark Ward in The Observer #ContaminatedBlood
0104
Reposted by GlycoTime Digests
Ben Kellman @bkell1123.bsky.social · 18/11/2024
Important numbers to know for the difficult years ahead. Also worth asking if the "next dollar" will yield similar returns. How much more would we need to invest in research to see less than a 250% return?
031
Reposted by GlycoTime Digests
Daniel Bojar @dbojar.bsky.social · 18/11/2024
If you're interested in glycobioinformatics in Python (or via a GUI), we've got glycowork for you:-) It just had its v1.4 update & we develop it since ~3.5 years You can use it to draw SNFG-glycans, annotate glycan motifs, convert nomenclatures, match compositions to sequences, train AI models, etc
github.com
GitHub - BojarLab/glycowork: Package for processing and analyzing glycans and their role in biology.
Package for processing and analyzing glycans and their role in biology. - BojarLab/glycowork
042
Reposted by GlycoTime Digests
Oded Rechavi @odedrechavi.bsky.social · 17/11/2024
I'm reviewing your grant
11285
Reposted by GlycoTime Digests
Nick Riley @nmriley.bsky.social · 13/11/2024
Our Autonomous Dissociation-type Selection (ADS) method is published in JPR! This intelligent data acquisition approach uses RTLS to make fragmentation decisions as data is collected to improve glycoproteome sampling. Congrats to all involved! #glycotime #TeamMassSpec pubs.acs.org/doi/10.1021/...
pubs.acs.org
Autonomous Dissociation-type Selection for Glycoproteomics Using a Real-Time Library Search
Tandem mass spectrometry (MS/MS) is the gold standard for intact glycopeptide identification, enabling peptide sequence elucidation and site-specific localization of glycan compositions. Beam-type col...
24712
Reposted by GlycoTime Digests
Harrison Specht @harrisons.bsky.social · 14/11/2024
Jesse G Meyer and more than 40 collaborators made a practical introduction to Proteomics. github.com/jessegmeyerl...
github.com
GitHub - jessegmeyerlab/proteomics-tutorial
Contribute to jessegmeyerlab/proteomics-tutorial development by creating an account on GitHub.
33912
Reposted by GlycoTime Digests
Daniel Hurdiss @danielhurdiss.bsky.social · 15/11/2024
Sharing recent publications just for fun (part 1). Here, we explored neutralizing epitopes in the porcine deltacoronavirus spike glycoprotein. 🐖 📄 www.nature.com/articles/s41... We found that a mAb targeting the N-terminus can trigger partial opening, perhaps mimicking a co-receptor interaction.
0328
Reposted by GlycoTime Digests
Hiren Joshi @glyco.me · 12/11/2024
New bit of work from CCG, with our newest cellular framework - GlycoCarrier www.nature.com/articles/s41...
nature.com
Mammalian cell-based production of glycans, glycopeptides and glycomodules - Nature Communications
Access to defined human glycans is crucial for biomedical research. Here, authors report Glycocarriers, a mammalian cell-based method for the sustainable and scalable production of O-, N-glycans, and ...
1219
Reposted by GlycoTime Digests
Amulya Sreekumar @amulyasreekumar.bsky.social · 12/11/2024
As someone who has gained a lot of knowledge and career advice from fellow glycobiologists, I wanted to recreate a space for discussion on Bluesky. Here's a starter pack with some glycobiology users to get started. Please comment/DM me to get added to the #glycotime starter pack go.bsky.app/CN9pS3u
243017
Reposted by GlycoTime Digests
Elisa Fadda @elisafadda.bsky.social · 17/11/2024
I'll be giving a talk on Tue about one of my 🔝 fav topics (besides cats). In the meantime, 1) select your fav glycoprotein PDB/AF or own and 2) try to rebuild its glycans with GlycoShape.org 😊 I promise, it's better than Wordle and the results will 🤯😎
glycoshape.org
GlycoShape
GlycoShape is an OA database of glycans 3D structural data and information that can be downloaded or used with Re-Glyco to rebuild glycoproteins from the RCSB PDB or EMBL-EBI AlphaFold repositories
0218
Reposted by GlycoTime Digests
AJ te Velthuis @ajtevelthuis.bsky.social · 13/11/2024
We have found a capped flu RNA that was hiding in plain sight. In our preprint we show how this RNA activates RIG-I through a non-canonical mechanism. Fantastic work by Liza Elshina and many thanks to collaborators @alistairrussell.bsky.social and Joe Marcotrigiano! biorxiv.org/content/10.1...
14316